Meeder Advisory Services Inc. Increases Position in Agilent Technologies, Inc. (NYSE:A)

Meeder Advisory Services Inc. boosted its holdings in Agilent Technologies, Inc. (NYSE:A) by 1.4% in the third quarter, HoldingsChannel reports. The firm owned 7,451 shares of the medical research company’s stock after purchasing an additional 104 shares during the period. Meeder Advisory Services Inc.’s holdings in Agilent Technologies were worth $1,106,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of A. Crewe Advisors LLC increased its position in shares of Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares during the last quarter. Livelsberger Financial Advisory acquired a new position in Agilent Technologies in the third quarter worth about $28,000. Ridgewood Investments LLC bought a new stake in Agilent Technologies in the second quarter valued at about $29,000. Ashton Thomas Securities LLC acquired a new stake in Agilent Technologies during the third quarter valued at approximately $31,000. Finally, Fortitude Family Office LLC raised its stake in Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after buying an additional 95 shares in the last quarter.

Insiders Place Their Bets

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This represents a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 7.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 11,995 shares of company stock worth $1,739,510.

Agilent Technologies Stock Down 0.1 %

A opened at $126.92 on Tuesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The company has a market capitalization of $36.47 billion, a PE ratio of 26.33, a P/E/G ratio of 5.59 and a beta of 1.07. The stock’s fifty day moving average is $138.50 and its 200-day moving average is $137.92. Agilent Technologies, Inc. has a one year low of $112.39 and a one year high of $155.35.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the previous year, the business earned $1.43 earnings per share. Agilent Technologies’s revenue for the quarter was down 5.6% compared to the same quarter last year. On average, equities analysts predict that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were issued a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies’s payout ratio is 19.50%.

Analyst Ratings Changes

A has been the subject of a number of research analyst reports. UBS Group boosted their price target on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Barclays lifted their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a report on Tuesday, October 15th. Wells Fargo & Company began coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price on the stock. Evercore ISI lifted their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Finally, TD Cowen increased their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $144.36.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.